Get started

Nyse

DISNEY BACK TO 95 AFTER EARNINGS Disney, a global entertainment conglomerate, has been facing challenges in recent years. The company’s traditional revenue streams, such as theme parks and movie theaters, have been hit hard by the COVID-19 pandemic1. Furthermore, Disney’s streaming service, Disney+, while successful, is facing stiff competition from other platforms like Netflix, Amazon Prime, and HBO Max1. Here’s a short idea based on this information: Short Thesis: Disney’s stock could be overvalued given the challenges it faces. The impact of the pandemic on its traditional businesses and the intense competition in the streaming market could put pressure on its earnings. Therefore, there could be a potential short opportunity. Key Risks: Disney’s diverse portfolio of assets and strong brand recognition could help it weather these challenges. The success of Disney+ and the potential recovery of its traditional businesses as the pandemic eases could lead to a turnaround in the company’s fortunes.
NYSE:DISShort
by NYRUNSGLOBAL
PAY PAL TO 67 AFTER EARNINGS Short Thesis: PayPal’s stock has been underperforming due to increased competition and growth concerns. Despite the company’s efforts to reinvent itself through AI-based products, it’s uncertain whether these initiatives will be enough to regain investor confidence and compete effectively in the rapidly evolving fintech landscape. Therefore, there could be a potential short opportunity. Key Risks: The success of PayPal’s new AI-based products and services could lead to a turnaround in the company’s fortunes. Also, any positive changes in the fintech landscape or regulatory environment could benefit PayPal.
NASDAQ:PYPLShort
by NYRUNSGLOBAL
Amer Sports IPO: A Risky Swing or a Strategic Play? Amer Sports ( NYSE:AS ), the Finnish athletic company renowned for iconic brands such as Wilson tennis rackets and Arc’teryx, made headlines with its recent initial public offering (IPO) on the New York Stock Exchange (NYSE). Despite a tepid market reception, marked by a 5% opening pop, Amer Sports' ( NYSE:AS ) decision to debut at a discounted $13 per share, down from an initially targeted range of $16 to $18, has raised eyebrows in financial circles. Challenging Economic Landscape: The IPO took place against the backdrop of a challenging economic landscape, as Federal Reserve Chair Jerome Powell's reluctance to signal rate cuts cast a shadow over market sentiment. This caution has left some questioning whether Amer Sports' decision to discount its IPO was a prudent move in such uncertain times. Debt Burden and Financial Performance: Amer Sports' ( NYSE:AS ) financial health has also come under scrutiny, with the company grappling with a substantial debt load of $2.1 billion. Compounding concerns, the company has yet to turn a profit between 2020 and September 2023, a period that saw a net loss of $113.9 million despite a revenue increase from $2.35 billion to $3.05 billion over the same time frame. China Connection: Amer Sports'( NYSE:AS ) ties to China have further fueled investor skepticism. The company's business in Greater China has surged, with a notable uptick from 8.3% in 2020 to 19.4% in the nine months ending September 30, 2023. This growth comes at a time when geopolitical tensions between the U.S. and Beijing are on the rise. The CEO, James Zheng, has emphasized the importance of China to Amer ( NYSE:AS ) but also stressed the company's global presence, with North America and Europe still representing the lion's share of its business. Market Sentiment and IPO Trends: The lackluster debut of Amer Sports ( NYSE:AS ) adds to the recent string of underwhelming IPOs, including that of German shoemaker Birkenstock. The IPO market, once anticipated to witness a resurgence, has struggled to regain its footing, raising questions about the overall appetite for new public offerings in the current economic climate. Conclusion: As Amer Sports ( NYSE:AS ) navigates the complexities of a discounted IPO, a heavy debt burden, and its expanding footprint in China, the company's future trajectory remains uncertain. Investors will be closely monitoring how Amer Sports ( NYSE:AS ) addresses its financial challenges and navigates the dynamic global market, especially given its significant exposure to China. The coming months will reveal whether this strategic move will position Amer Sports ( NYSE:AS ) as a resilient player in the athletic space or if it will face continued headwinds in an unpredictable economic landscape.
NYSE:ASLong
by DEXWireNews
AMAZON ENTER 162 TP 165 AFTER EARNINGS NASDAQ:AMZN ENTER 162 TP 165 AFTER EARNINGS Amazon Revenue Growth: Analysts expect Amazon’s revenues to rise 11.4% YoY in Q4 and hit a record high of $166.2 billion1. The company’s Q3 operating margin of 7.8% was the highest since early 20211. Profitability: Amazon posted record net profits in Q3, and the metric almost hit a milestone of $10 billion1. Analysts expect Amazon to post per-share earnings of $0.81 in Q4, which is 285% higher than the corresponding quarter last year1. Cost-cutting Initiatives: Amazon has undertaken several cost-cutting initiatives that have helped to improve its profits, despite slowing revenue growth1. Bullish Target Price: The 210 price target from Wedbush places the firm among the most bullish for Amazon stock2. The average 12-month target price for AMZN stock from Wall Street analysts is 179, according to FactSet2. Amazon Web Services (AWS): The top-line growth of Amazon’s enterprise-focused AWS has been gradually falling, and YoY revenue growth slipped to an all-time low of 12% in Q31. However, Amazon has stressed that the segment’s growth is "stabilizing"1. Consumer Sentiment and Business Spending: During their Q3 earnings call, Amazon said consumers are trading down amid still-high inflation and a challenging macro environment1. It will be crucial to watch for commentary on the business spending environment in 2024
NASDAQ:AMZNLong
by NYRUNSGLOBAL
META ENTER 408 TP 416 AFTER EARNINGS NASDAQ:META Growth and Profitability: Bank of America Securities analyst Justin Post maintains a bullish stance on Meta stock, citing potential for growth and profitability1. His analysis anticipates a fourth quarter revenue surpassing the consensus estimates, driven by a 22% year-over-year increase1. This optimistic outlook is fueled by the positive momentum of Reels and advancements in artificial intelligence1. Monetization of Reels and Messaging: Post believes that Meta is in the early stages of monetizing Reels and messaging, and that ongoing AI and machine learning integrations will enhance user engagement and advertising spend1. New Products Leveraging AI: The anticipation of new products leveraging Meta’s AI assets, combined with an attractive valuation excluding Metaverse losses, further supports the Buy recommendation1. Bullish Diagonal Spread: Some investors are going bullish on Meta stock with a diagonal spread2. This strategy involves buying a call option and selling a shorter-term call option against it2. Advancements in Tech Tools: Meta continually advances its next-gen tech tools, like their AI Code Llama for coding assistance3. Investment in Metaverse: Meta Platforms is investing billions into the metaverse4. Changes to iOS have stalled Meta’s top line, but Wall Street thinks this will be short-lived ENTER 408 TP 416 After Earnings
NASDAQ:METALong
by NYRUNSGLOBAL
LI AUTO TP 35 BEFORE EARNINGS Li Auto, a China-based electric vehicle (EV) manufacturer, has been receiving positive attention from investors and analysts. Here are some reasons why: Ambitious Goals: Li Auto’s management has set an ambitious vehicle-delivery goal1. They aim to sell at least 400,000 units of the Li L7, Li L8, and Li L9 in 20241, which would exceed their total of 376,030 vehicles sold in 20231. Innovative Ideas: Li Auto is trying out an interesting idea similar to what Nio is doing1. This could be referring to Nio’s flagship showroom, known as Nio House, which is a unique vehicle showroom that resembles a home1. Strong Partnerships: Li Auto has a partnership with Nvidia, where Nvidia’s Drive Thor autonomous driving chip will power Li Auto’s ET9 electric sedan1. New Launches: Li Auto is gearing up to launch its flagship multi-purpose vehicle, the Li MEGA, on March 11. Positive Analyst Recommendations: Li Auto Inc. Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.10, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations made by five brokerage firms
NASDAQ:LILong
by NYRUNSGLOBAL
2
Walmart's Bold Move: A 3-for-1 Stock Split to Empower Associates Walmart Inc. (NYSE: NYSE:WMT ) has recently announced a significant development in its financial strategy – a 3-for-1 stock split. The decision, driven by a commitment to inclusive shareholder participation and a desire to align with founder Sam Walton's vision, reflects Walmart's ongoing dedication to its associates and a long-standing legacy of fostering financial health. We will delve into the details of this strategic move, its implications for investors and associates, and the broader context within which Walmart (NYSE: NYSE:WMT ) operates. Empowering Associates through Accessibility: At the heart of Walmart's decision lies a commitment to its associates. With over 400,000 participating in Walmart's Associate Stock Purchase Plan, the 3-for-1 stock split aims to make share ownership more accessible. Walmart's President and CEO, Doug McMillon, echoes Sam Walton's belief that keeping share prices within reach for associates is crucial for fostering a sense of unity and shared success. By reducing the share price through the stock split, Walmart (NYSE: NYSE:WMT ) is encouraging its workforce to actively participate in the company's growth journey. Historical Context and Sam Walton's Vision: Walmart's decision to split its shares resonates with the principles laid down by its founder, Sam Walton. Walton believed in the power of unity and famously said, "We're all in this together. That's the secret." The stock split aligns with Walton's vision of creating opportunities for associates to benefit from the company's success. Walmart's (NYSE: NYSE:WMT ) focus on its associates' financial health, coupled with a commitment to providing good jobs and attractive benefits, underscores a tradition that spans over six decades. Practical Implications for Investors: For existing shareholders, the stock split means a distribution of two additional shares for every share held. This not only dilutes the share price but also increases the total number of outstanding shares from approximately 2.7 billion to 8.1 billion. The move is expected to make Walmart's (NYSE: NYSE:WMT ) stock more attractive to a broader range of investors, potentially enhancing liquidity and market participation. Market Reaction and Technical Outlook: Technically, Walmart's stock is currently in a rising trend channel, indicating increasing optimism among investors. The recent break above the resistance level at $165 signals a potential upward trajectory. Investors are likely to respond positively to the stock split, viewing it as a strategic move that reinforces Walmart's commitment to growth and inclusivity. Conclusion: Walmart's (NYSE: NYSE:WMT ) decision to undergo a 3-for-1 stock split is a strategic move with deep-rooted connections to its founder's vision and a commitment to associates' financial well-being. As the company enters a new phase with an increased number of outstanding shares, investors and associates alike are poised to benefit from this bold initiative. The stock split not only aligns with Walmart's (NYSE: NYSE:WMT ) historical principles but also positions the retail giant for continued success in an ever-evolving market.
NYSE:WMTLong
by DEXWireNews
Pfizer's Surprising Turnaround: A Resilient JourneyIn an unexpected twist, Pfizer ( NYSE:PFE ), the U.S. pharmaceutical giant, has defied market expectations by reporting a surprise quarterly profit. This surprising turnaround can be attributed to the resilient demand for COVID-related products, outperforming the company's own projections. The earnings report for the fourth quarter revealed adjusted earnings of 10 cents per share, a stark contrast to the anticipated loss of 22 cents per share by analysts. Pandemic Fallout and Pfizer's Struggles: Investors had been skeptical about Pfizer's ( NYSE:PFE ) prospects as pandemic concerns waned and substantial revenues from COVID vaccine and treatment sales dwindled. The company faced an additional setback with its experimental obesity drug, contributing to a further decline in its stock value. This downturn reached levels reminiscent of the pandemic sell-off in 2020, resulting in a staggering $100 billion loss in market capitalization in 2023. Resilient COVID Product Demand: The silver lining for Pfizer ( NYSE:PFE ) emerged from the sustained demand for its COVID products, namely the antiviral treatment Paxlovid and the widely-used COVID vaccine Comirnaty, developed in collaboration with German partner BioNTech. Despite a significant drop in revenue from $57 billion in 2022 to $12.5 billion in 2023, these products played a crucial role in Pfizer's unexpected profitability. Strategic Initiatives for Recovery: To counter the adverse market trends, Pfizer ( NYSE:PFE ) has embarked on a strategic journey aimed at regaining profitability. A $4 billion cost-cutting program and internal restructuring form the cornerstone of the company's recovery plan. With these measures in place, Pfizer ( NYSE:PFE ) is optimistic about driving revenue growth through its cancer treatments, particularly following the $43 billion acquisition of cancer drugmaker Seagen. Additionally, the introduction of a new RSV vaccine is poised to contribute to the company's resurgence. Outlook and Future Projections: Pfizer's ( NYSE:PFE ) bold move to cut costs and refocus on high-potential areas, such as cancer treatments and vaccine development, has instilled confidence among investors. The company's projections for 2023 include an expected $1 billion in Paxlovid sales and $11.5 billion in Comirnaty sales. This outlook, combined with a 1.9% rise in premarket trading, suggests that Pfizer's strategic initiatives are resonating positively with the market. Conclusion: Pfizer's ( NYSE:PFE ) unexpected quarterly profit signifies a notable turnaround for the pharmaceutical giant. The company's ability to adapt to changing market dynamics, capitalize on resilient product demand, and implement strategic measures for recovery underscores its resilience. As Pfizer ( NYSE:PFE ) charts a course toward profitability, investors and industry observers are keenly watching how the company's strategic initiatives will shape its future in a post-pandemic landscape.
NYSE:PFELong
by DEXWireNews
Starbucks to 98 Plus After Earnings !!Financial Performance: In 2023, Starbucks’s revenue was $35.98 billion, an increase of 11.55% compared to the previous year’s $32.25 billion. Earnings were $4.12 billion, an increase of 25.69%2. Analyst Forecast: According to 21 analysts, the average rating for SBUX stock is “Buy.” The 12-month stock price forecast is $114.35, which is an increase of 23.22% from the latest price2. Dividend Yield: Starbucks has a dividend yield of 2.4569%1, which could be attractive to income-focused investors. Growth Estimates: The growth estimate for the next 5 years (per annum) is 16.63%3 TP 98
NASDAQ:SBUXLong
by NYRUNSGLOBAL
Apple Back to 182 Consolidation AreaApple Inc. Explore A Bearish Perspective on Apple Stock Apple Inc., the tech giant known for its innovative products and services, has been a darling of Wall Street for many years. However, some analysts are turning bearish on the company’s stock. Here’s a closer look at why. Underperformance in 2023 Despite gaining an impressive 49% in 2023, Apple’s stock was the worst-performing FAANG constituent of the year1. The company reported negative revenue growth in all four quarters of 2023, the first time since 2001 that the company’s revenues fell YoY for four straight quarters1. Downgrades in 2024 The start of 2024 hasn’t been positive for Apple either, with three brokerages downgrading the stock within the first two weeks of the year1. Redburn, Piper Sandler, and Barclays have all downgraded the stock1. While Redburn and Piper Sandler now rate the stock as a “Hold” or equivalent, Barclays downgraded the stock to a “Sell” equivalent with a Street-low target price of $1601. Concerns Over iPhone Sales Some brokerages are turning bearish on Apple amid fears of an extended slowdown in iPhone sales1. Analysts are especially worried about the outlook for iPhone sales in China, which is the company’s third-biggest market behind the U.S. and Europe, and accounted for around 19% of its fiscal year 2023 revenues1. Apple is facing tough competition from domestic Chinese smartphone companies like Huawei and Xiaomi1.
NASDAQ:AAPLShort
by NYRUNSGLOBAL
Humana's Stock Plunges But shows Signs of a Reverse Trend Humana Inc., ( NYSE:HUM ) the second-largest Medicare Advantage company in the U.S., has sent shockwaves through the health insurance sector by revising its earnings guidance for 2025 and projecting 2024 profits well below analysts' expectations. The stock plummeted as much as 15%, marking the most significant intraday drop since June. This unexpected development has ignited concerns about the profitability of private Medicare plans and their potential impact on seniors' healthcare costs. The Medicare Advantage Dilemma: Humana's grim outlook stems from challenges faced by private Medicare plans, which have been a significant source of growth for health insurers in recent years. Rising medical costs are forcing Humana ( NYSE:HUM ) to consider raising prices and reducing benefits to maintain profit margins. Executives revealed on a conference call that this move may trigger a broader industry repricing of plans in the upcoming year, potentially signaling the end of the Medicare Advantage boom. Industry-Wide Ripple Effect: Humana's forecast has not only impacted its own stock but has also led to a sector-wide sell-off. Competitors such as UnitedHealth Group Inc., Cigna Group, CVS Health Corp., and Centene Corp. experienced substantial declines in their stock prices. The reasons behind the surge in medical costs vary among insurers, adding uncertainty to the already turbulent sector. Regulatory Changes and Emerging Trends: Several factors contribute to the challenging landscape for health insurers. The U.S. government's proposed changes to payment rates and plans to recoup past overpayments are colliding with an increase in medical costs as patients resume deferred care from the pandemic. These changes are being phased in over the next three years, creating additional pressure on insurers. Humana's Long-Term Prospects: The revised earnings guidance suggests a significant setback for Humana, as the projected adjusted earnings for 2024 are expected to be around $16 per share, a level not seen since 2018. Analysts express surprise and skepticism about the company's growth plans, with some doubting the feasibility of achieving a $6 to $10 per share growth in 2025. Market Reaction and Investor Concerns: Humana's dismal performance has ignited concerns among investors about the broader health insurance industry. Analysts are questioning whether the company can return to its long-term multiple and express concerns about slowing demographic trends in the 65+ market, which are expected to moderate in the second half of the 2020s. Conclusion: Humana's unexpected downturn serves as a stark reminder of the challenges facing health insurers, particularly those heavily invested in Medicare Advantage plans. The industry is at a crossroads, navigating regulatory changes, surging medical costs, and an uncertain economic landscape. Investors will be closely watching how competitors respond to these challenges and whether the Medicare Advantage boom is indeed coming to an end.
NYSE:HUMLong
by DEXWireNews
LCID analysis ⏰ let's discuss :-: Hello 👋 it's me your RAJ 🙂 professional trader ✨ This idea 💡 is completely my own analysis to explain situation _&_ market conditions of NASDAQ:LCID How this chart valid for long term 📌 explained clearly based on technical #TA 📌 #DYOR ::-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:-:: Frankly speaking 🗣️ I am full time trader in Crypto 🔮 part time in stocks to save my money 💰 Based on my friend request , i am doing 📌 analysis ⏰ based on technical analysis #TA I don't know it's fundamental and some other things to measure this as potential or bad stock based on technical i will talk 🦜 If u have experience and good knowledge in stock market especially usstock Pls let me know about this company NASDAQ:LCID it helps me to check price in other conditions :-) let's go 👀 In my opinion || chart 📉📈 looking too bad // continues downfall Best area enter is ::👉 $2.6 - $4.1 👈 Best area to exit 🎯 :: $5.3 - $10.4 - $17 - $34 Stop 🛑 when price goes below $2.5 weekend candle close below Invalid 📌 to invest Don't use 100% liquid 💰 it's high risk , so prefer 5-10% liquid 💰 on ur portfolio Let me know points to consider on this stock , so i work and i will submit u those 👀 I always do analysis on crypto stocks _&_ large cap // rest of things i don't know much __________________________________________________________________________________________ 🪩 disclaimer : ▶️ TQ u for supporting 💚 follow idea 💡 get updates everytime ⏰ when I updated 📌 Note 👀 👉 keeping comments , reacting with emojis , pointing us is very easy to some people They think 💬 what they see 📌 that was knowledge 📌 We need to learn market in many ways and should get adopted with experience, TECHNICAL ANALYSIS won't help understanding market structure and understanding bull 🐂 and bear 🐻 is more important Economical conditions Fundamentals Technical News Sentiments Checking macro to micro having good plan and build it is very important ☺️ Some Times market easily turn suddenly bear // bull 🤣 even we need to catch 🫴 those movements is also very important ☺️ 💛 I hope i cleared my view 🙂 if any points if I miss I will add in update 📌 post Try to understand, try to learn - try to move with flexibility with market is important Have good day 😊
NASDAQ:LCIDLong
by raj5_7_5
4